UBS Raises Price Target#
UBS has increased its price target for Procter & Gamble stock (NYSE: PG) from $166 to $172. This adjustment comes after the company reported its third-quarter results, which showed stronger sales than anticipated.
Strong Sales Performance#
Procter & Gamble achieved organic sales growth of 3.0% for its fiscal third quarter, surpassing analysts' expectations by 109 basis points. This means the company's sales growth was better than what most experts predicted. Despite facing challenges with gross and operating margins, the overall earnings exceeded forecasts, thanks to a solid gross profit margin of approximately 51%.
Future Earnings Outlook#
While Procter & Gamble reiterated its earnings per share forecast for fiscal 2026, it now expects results to be at the lower end of its previously stated range. The company cited rising commodity costs as a significant challenge, estimating a $150 million negative impact on its profits. Management also mentioned a potential slowdown in growth for the fourth quarter due to timing factors, although they noted that market trends are stabilizing and improving.
Analyst Reactions#
Following Procter & Gamble's impressive financial results, several analysts have adjusted their price targets. TD Cowen raised its target to $150 from $142, while Jefferies increased its target to $177 from $175, both citing positive trends in volume growth and market share. BofA Securities and RBC Capital also adjusted their targets, reflecting a favorable analyst response to the company's recent performance.